You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Immune checkpoint inhibitor plus tyrosine kinase inhibitor with or without transarterial chemoembolization for unresectable hepatocellular carcinoma
- 2. Histogram analysis of multiple mathematical diffusion-weighted imaging models for preoperative prediction of Ki-67 expression in hepatocellular carcinoma
- 3. Nwd1 gene deletion triggers MASH-like pathology in mice
- 4. Unlocking the hidden proteome: The role of coding circular RNA in cancer
- 5. How environmental exposures affect genes and increase cancer risk
- 6. Secret boss of the liver: Star-shaped cells that promote fibrosis also regulate liver health
- 7. Prostate cancer is not a death knell, study shows
- 8. Pfizer and Arvinas's HER2-breast cancer drug extends PFS in certain patients
- 9. Breast Cancer Diagnostics Market Set for 6.9% CAGR Growth, projected to Hit USD 12.45 Billion by 2035
- 10. Abemaciclib in combination with therapies for patients with metastatic breast cancer: a phase 1b study
Last updated at 17:54 GMT
Hot News Makers
Health/Pharma Companies
-
21907.46
-
17061.46
-
11899.82
-
10970.69
-
10176.71
-
6379.65
-
6171.23
-
5489.07
-
5162.49
-
4344.40
Drugs, Treatments, Trials
-
23137.34
-
19705.74
-
7618.90
-
7358.37
-
6252.56
-
5517.63
-
4842.01
-
2991.86
-
2977.54
-
2834.72
Last updated at 17:10 GMT
